Teva Pharmaceutical Industries Ltd ADR buy UBS Group AG
Start price
03.09.24
/
50%
€16.90
Target price
03.09.25
€23.55
Performance (%)
-7.40%
Price
27.09.24
€15.65
Summary
This prediction is currently active. With a performance of -7.40%, the BUY prediction for Teva Pharmaceutical Industries Ltd ADR by UBS_Group_AG is down slightly. This prediction currently runs until 03.09.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Teva Pharmaceutical Industries Ltd ADR | -0.318% |
iShares Core DAX® | 3.523% |
iShares Nasdaq 100 | 1.026% |
iShares Nikkei 225® | -0.063% |
iShares S&P 500 | 0.557% |
Comments by UBS_Group_AG for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at UBS Group AG from $24.00 to $26.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by UBS_Group_AG for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€15.70
11.07.24
11.07.24
€22.04
11.07.25
11.07.25
-0.32%
27.09.24
27.09.24
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€8.94
27.11.23
27.11.23
€11.87
27.11.24
27.11.24
75.06%
27.09.24
27.09.24